Nephros (NEPH) EPS (Diluted) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Nephros (NEPH) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -12.16% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 24.50% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 19.81% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 50.83% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -6.12% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 33.46% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 18.07% |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 65.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.85% |
| Mar 31, 2026 | 32.12% |
| Dec 31, 2025 | 51.29% |
| Sep 30, 2025 | 28.00% |
| Jun 30, 2025 | 29.82% |
| Mar 31, 2025 | 28.77% |
| Dec 31, 2024 | 29.42% |
| Sep 30, 2024 | 27.58% |
| Jun 30, 2024 | 49.99% |
| Mar 31, 2024 | 43.62% |
| Dec 31, 2023 | 25.46% |
| Sep 30, 2023 | 55.60% |
| Jun 30, 2023 | 49.07% |
| Mar 31, 2023 | 48.26% |
| Dec 31, 2022 | -32.87% |
| Sep 30, 2022 | -28.13% |
| Jun 30, 2022 | 14.36% |
| Mar 31, 2022 | -12.97% |
| Dec 31, 2021 | -13.52% |
| Sep 30, 2021 | -31.13% |